Abstract
Introduction:
Trichosanthes kirilowii Maxim has been well-documented for its pharmacological effects in alleviating constipation. Notably, polysaccharides, a class of natural macromolecules, demonstrate significant therapeutic potential for constipation management. Nevertheless, the preventive effect of Trichosanthes kirilowii polysaccharide (TKP) against functional constipation and its underlying mechanisms remain poorly understood.
Methods:
In this study, a mouse model of diphenoxylate-induced functional constipation was established. Meanwhile, the laxative effect of TKP on the fecal excretion function, intestinal inflammatory response, neurotransmitter secretion and gut microbiota composition were evaluated.
Results:
Treatment with the TKP alleviated the constipation-associated pathological symptoms in mice through enhancing the gastrointestinal (GI) transit ratio and improving defecation function. Moreover, TKP supplementation modulated the secretion levels of neurotransmitters in the serum of mice, elevating excitatory neurotransmitters (SP, MTL and ACH), while suppressing inhibitory neurotransmitters (NO, VIP and ET-1). Additionally, TKP reduced the level of MDA, and enhanced the activities of SOD and GSH-Px, effectively attenuating oxidative stress. Under TKP administration, colonic levels of pro-inflammatory cytokines (IL-6, IL-1β and TNF-α) were significantly suppressed, while upregulating the expression of tight junction proteins (ZO-1 and occludin). Crucially, TKP increased the production of short-chain fatty acids (SCFAs), and modulated the gut microbiota by restoring its abundance and diversity in constipated mice.
Conclusion:
Collectively, these findings demonstrated that TKP could ameliorate diphenoxylate-induced functional constipation in mice, providing a pharmacological foundation for its development as a novel therapeutic agent against constipation.
1 Introduction
Functional constipation, as a kind of gastrointestinal dysfunction without organic disease, is common across all age groups. The clinical symptoms of functional constipation mainly include difficulty defecating, reduced frequency of defecation and dry stool (). Studies have shown that the global prevalence of functional constipation is from 10.1% to 15.3%, and its occurrence is closely related to multiple factors such as dietary habit, mental state, psychological status, genetics and living environment (; ). Chronic constipation significantly impairs quality of life and may predispose individuals to various disorders, including cardiovascular, gastrointestinal, and neurological diseases (; ; ; ). Current constipation management relies on laxatives and prokinetic agents, while chronic administration may induce drug dependence (). Therefore, it is of great significance to develop safe and effective natural medicines to prevent and relieve constipation.
Polysaccharides, as a class of natural macromolecular compounds with a variety of biological activities, are widely found in plants, animals and microorganisms (). In addition to immunomodulation, antioxidant, anti-inflammatory and other pharmacological effects (; ), polysaccharides also play an important role in regulating gut microbiota, enhancing intestinal peristalsis and improving intestinal barrier function (), which can effectively improve the symptoms of constipation (). For example, Dendrobium officinale polysaccharide was proved to exert laxative effect through enhancing the gastrointestinal transit ratio, regulating gastrointestinal hormone levels and increasing fecal water content in constipated mice (). Gastrodia elata Blume polysaccharide significantly increased the abundance of probiotics (such as Bifidobacterium, Collinsella, Prevotella, and Faecalibacterium) and inhibited the growth of pathogenics (such as Shigella, Dorea, Desulfovibrio, and Blautia) to regulate the gut microbiota. Meanwhile, Gastrodia elata Blume polysaccharide was able to maintain gut health by regulating gut microbiota and increasing the production of beneficial metabolite such as short-chain fatty acids (SCFAs) (). Atractylodes macrocephala polysaccharide could reduce constipation-related symptoms by restoring the balance of gut microbiota and affecting related metabolic pathways to increase the production of SCFAs and up-regulate the expression levels of 5-hydroxytryptamine (5-HT) and chromogranin A (CgA) in constipated mice (). As an essential traditional Chinese medicine, Trichosanthis Fructus is the dry ripe fruits of Trichosanthes kirilowii Maxim or Trichosanthes rosthornii Harms of the Cucurbitaceae family. It is traditionally employed for its therapeutic effects in clearing heat and resolving phlegm, moistening the intestines, and promoting bowel movements (). Among its main active components, Trichosanthes kirilowii polysaccharide (TKP) has garnered growing attention due to their pharmacological potential. Recent studies have demonstrated that TKP exhibited the diverse biological activities, including antioxidant, anti-inflammatory, immunomodulatory, lipid-lowering, and gut microbiota-regulating effects (; ; ; ; ). However, the preventive effect of TKP on functional constipation and its mechanism are still unclear.
Consequently, the preventive effect of TKP on functional constipation in mice was investigated. In this study, the model of functional constipation in mice induced by diphenoxylate was established. To evaluate the laxative effect of TKP, the study examined the fecal excretion function, intestinal inflammatory response, neurotransmitter secretion and gut microbiota composition. These findings provide a theoretical basis for the prevention of functional constipation by TKP.
2 Materials and methods
2.1 Materials
The flesh of Trichosanthes kirilowii was collected from the Pingyin County, Shandong Province. Diphenoxylate was purchased from Beijing Lihua Cun Trade Co. Ltd. Bisacodyl was obtained from Sigma-Aldrich.
2.2 Preparation of TKP
The crude polysaccharide from Trichosanthes kirilowii (TKP) was isolated using the water extraction and alcohol precipitation method, based on the previous study (). Briefly, the flesh of Trichosanthes kirilowii was subjected to triple extraction with boiling water. The combined aqueous extracts were filtered to remove insoluble residues and then was concentrated. The concentrate was mixed with absolute ethanol to achieve a final ethanol concentration of 80% (v/v) for polysaccharide precipitation and stored at 4 °C overnight. Subsequently, the resulting precipitate was redissolved in distilled water, and further purified to obtain the crude polysaccharide fraction. Then, the crude polysaccharide was defatted with petroleum ether. Finally, the product was freeze-dried to obtain TKP. The yield of TKP was 0.68%. The chemical composition of TKP was total sugar (93.24%, w/w), ash (1.28%, w/w), and protein (3.87%, w/w). The monosaccharide composition of TKP was arabinose (35.32%, w/w), glucose (24.63%, w/w), galactose (22.90%, w/w), rhamnose (4.31%, w/w), mannose (6.39%, w/w), fructose (0.93%, w/w), and galacturonic acid (5.51%, w/w) (Supplementary Table 1). The content of total sugar was determined by the phenol-sulfuric acid method. The contents of ash and protein were measured using the previous methods (; ). The monosaccharide composition was analyzed using a Thermo ICS 5000 ion chromatography system (ICS 5000, Thermo Fisher Scientific, United States).
2.3 Animals and experimental design
Kunming mice (female, 4 weeks old; Beijing Vital River Laboratory Animal Technology Co., Ltd.) were housed under controlled conditions (23–25 °C, 40%–60% humidity, and 12 h light/dark). All mice were acclimated for 7 days before constipation experiments and then randomly divided into six groups (n = 8/group) as follows: the normal control (NC) group, the model control (MC) group, the bisacodyl positive control (BC) group, the low-dose TKP (TKP-L) group, the middle-dose TKP (TKP-M) group, the high-dose TKP (TKP-H) group. Functional constipation was induced following the established method of . During the initial 14 days, the normal control (NC) and model control (MC) groups received equal volume of saline, while the bisacodyl control (BC) group was treated with bisacodyl (0.1 g/kg⋅bw/d). The experimental groups (TKP-L, TKP-M, and TKP-H) received TKP at doses of 300, 600, and 900 mg/kg⋅bw/d, respectively, based on the previous study (). Mice were administered test compounds via oral gavage at a volume of 10 mL/kg⋅bw/d. Subsequently, functional constipation was induced in MC, BC and TKP-treated groups by oral administration of diphenoxylate (30 mg/kg⋅bw/d) for three consecutive days, based on the previous study (). The model of constipation was performed after 14 consecutive days of TKP or control administration. The NC group continued to receive an equivalent volume of saline. Body weight, food intake, and water consumption were monitored daily in all mice.
At the end of these experiments, mice were euthanized under anesthesia for the collection of blood, cecum and colon. Blood samples were centrifuged (3,000 rpm, 10 min, 4 °C) to isolate serum. Cecal contents and the proximal colon were quickly taken and stored at −80 °C, and the distal colon tissues were immersed in formaldehyde solution.
2.4 Cell culture and treatment
RAW264.7 macrophage cells were cultured in dulbecco’s modified eagle medium (DMEM) supplemented with 10% (v/v) fetal bovine serum (FBS) in an incubator at 37 °C with 5% CO2 (). For toxicity test, RAW264.7 cells (2 × 104 cells/well) were inoculated into 96-well plates, and then treated with different concentrations (0.025, 0.05, 0.1, 0.2, 0.4, 0.8, 1.0, and 2.0 mg/mL) of TKP for 24 h, based on the previous study (). For further study, RAW264.7 cells (5 × 105 cells/well) were seeded on a six-well plate. A total of 1 μg/mL of lipopolysaccharide (LPS) was administered in model group, then TKP was added at the optimal concentration for 24 h.
2.5 Black fecal parameters
The determination of black fecal parameters was conducted according to the method described by , with minor modifications. After fasting for approximately 18 h, four mice in each group randomly selected to test defecation function were fed with 10% activated carbon solution (10 mL/kg⋅bw). The mice were immediately separated into a single cage and fed with basal diet and water. Observation was continued for 6 h, and first defecation time of black feces in each mouse was recorded. The wet weight and number of black feces in mice were measured.
2.6 Determination of the gastrointestinal (GI) transit ratio
Gastrointestinal (GI) transit ratio was determined according to the previous method (). Briefly, all mice were administered an activated carbon suspension (10 mL/kg⋅bw). A total of 25 min’ post-administration, four mice per group were randomly euthanized by cervical dislocation following blood collection. The entire small intestine was carefully excised from pylorus to cecum and laid straight without stretching on a chilled surface. Gastrointestinal (GI) transit ratio was calculated using the formula: GI transit ratio (%) = movement distance of activated carbon/the total length of small intestine × 100.
2.7 Measurement of biochemical indicators
The levels of substance P (SP), motilin (MTL), vasoactive intestinal peptide (VIP), acetylcholine (ACH), and endothelin-1 (ET-1) in the serum of mice were measured by ELISA kits according to the instructions (Shanghai Enzyme linked Biotechnology Co., Ltd., China). The contents of nitric oxide (NO), superoxide dismutase (SOD), glutathione peroxidase (GSH-Px), and malondialdehyde (MDA) were analyzed using commercial ELISA kits (Beyotime Biotechnology Co., Ltd.). Inflammation-associated factors including tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6), and interleukin-1β (IL-1β) in the colon of mice were measured using the corresponding kits (NeoBioscience technology Co. Ltd., China).
2.8 Histological and immunohistochemical analysis
Distal colon tissues were excised, rinsed with normal saline, and fixed in 4% paraformaldehyde for 24 h at room temperature. After routine dehydration, clearing, and paraffin embedding, tissues were sectioned at 4 μm, deparaffinized, rehydrated, and stained with hematoxylin and eosin (H&E) following standard procedures. Histopathological changes were observed under a light microscope (Nikon, Japan).
The expression levels of 5-hydroxytryptamine receptor 4 (HTR4) and vasoactive intestinal peptide receptor 1 (VIPR1) in colon tissues were assessed by immunohistochemistry. Briefly, the deparaffinized slides were blocked with 10% normal goat serum for 1 h. Sections were incubated with primary antibodies [anti-VIPR1 (BIOSS, 1: 300) and anti-HTR4 (Proteintech, 1: 300)], followed by secondary antibody (1: 200). Then, 3,30-diaminobenzidine (DAB) staining was visualized using a BX60 fluorescence microscope.
2.9 Western blotting analysis
The detailed procedure of Western blotting was conducted by the previously described (). Briefly, 20 mg of colonic tissue was homogenized in 200 μL of RIPA lysis buffer supplemented with protease inhibitor cocktail. Total protein concentration was quantified using BCA protein assay kit (Beyotime Biotechnology, China) according to the manufacturer’s protocol. Protein samples (20 μg) were resolved by 10% SDS-PAGE and subsequently transferred onto PVDF membranes. Then, membranes were blocked with 5% non-fat milk in TBST for 1 h at room temperature, then incubated overnight at 4 °C with the following primary antibodies (diluted 1: 1000): anti-ZO-1, anti-occludin, and anti-GAPDH (as loading control). After extensive washing, membranes were probed with HRP-conjugated secondary antibodies (1: 5,000 dilution) for 1 h at room temperature. Protein bands were visualized using enhanced chemiluminescence (ECL) reagent and quantified by densitometric analysis with ImageJ software (NIH, USA). The levels of relative protein expression were normalized to GAPDH.
2.10 Gut microbiota and short chain fatty acids (SCFAs) analysis
Total genomic DNA was aseptically extracted from cecal contents using the TIANamp Stool DNA Kit (Tiangen, Beijing, China). The V3–V4 hypervariable region of the 16S rRNA gene was amplified via PCR using universal primers (338F/806R). High-quality sequences were clustered into operational taxonomic units (OTUs) at 97% similarity using UCLUST (v1.2.22). Taxonomic classification was performed against the SILVA119 database (90% confidence threshold) in QIIME, followed by beta-diversity assessment through principal coordinate analysis (PCoA). Functional gene prediction was conducted using PICRUSt based on KEGG pathways. In addition, fecal samples (0.2 g) were subjected to gas chromatography-mass spectrometer (GC-MS) to quantify the concentrations of SCFAs.
2.11 Statistical analysis
All data were expressed as mean ± standard deviation (SD). Statistical analyzes and bar plots generation were performed using GraphPad Prism 8.0 (GraphPad Software, San Diego, United States). One-way ANOVA analysis followed by Tukey’s test were conducted to determine the differences between multiple groups.
3 Results
3.1 Effects of TKP on the fecal parameters in constipated mice
Changes in the body weight of mice were shown in Figure 1A. Throughout the experimental period, all groups exhibited progressive body weight gain, with comparable growth trajectories consistent with normal mice development. It was shown that TKP had no significant effect on the body weight of mice in the prevention of functional constipation.
FIGURE 1
The GI transit ratio of mice in each group was shown in Figure 1B. Compared with the NC group, the GI transit ratio in the MC group mice was significantly decreased by 30.55% (P < 0.01), indicating that the mouse model of functional constipation was successfully established. In comparison with MC group, the GI transit ratio of mice in the TKP-L, TKP-M, and TKP-H groups was increased by 8.1%, 18.1% (P < 0.05), and 20.6% (P < 0.01), respectively. The results showed that TKP effectively ameliorated the GI transit ratio in constipated mice. As illustrated in Figures 1C–E, the time of the first black feces, the total number and wet weight of black feces within 6 h were recorded. With regard to the NC group, the time of first black feces excretion in the MC group was prolonged by 54.8% (P < 0.005), while the number and wet weight of black feces were reduced by 48.3% (P < 0.01) and 45.1% (P < 0.005), respectively. It indicated that the mice in the MC group experienced apparent constipation symptoms. Intriguingly, the constipation symptoms of the TKP-treated groups showed varying degrees of improvement compared with the MC group. In terms of the time of first black feces, the three different dosage treatment groups exhibited the shorter first black stool time in comparison with the MC group (P < 0.01), with the TKP-H group showing the most pronounced reduction (by 27.9%). This effect was comparable to that observed in the BC group. Compared with the MC group, TKP-L, TKP-M, and TKP-H administration significantly increased by 13.3%, 60.0% (P < 0.05), and 66.7% (P < 0.05) in the total number of black feces, while the wet weight of black feces elevated by 11.7%, 42.9% (P < 0.05), and 63.7% (P < 0.01), respectively. These results demonstrated that TKP could improve the defecation function of constipated mice to relieve constipation symptoms, and the effect was most obvious in the TKP-H group.
3.2 Effect of TKP on biochemical indicators in constipated mice and RAW264.7 cells
The serum levels of antioxidant enzymes and neurotransmitters in constipated mice were measured. As depicted in Figures 2A–C, the contents of SOD and GSH-Px were significantly decreased as well as the increased level of MDA (P < 0.01 or P < 0.005). These findings suggested that constipation may impair intestinal antioxidant defenses, potentially inducing oxidative stress in the gastrointestinal tract. Compared with the MC group, the enzyme activities of SOD and GSH-Px were significantly increased in a dose-dependent manner in the TKP-treated groups, with the greatest increase of 53.6% and 33.4% in the TKP-H group, while the MDA content was reduced to normal value (all P < 0.01). It suggested that TKP could improve constipation by modulating serum-related oxidative mediators in constipated mice.
FIGURE 2
In order to explore the efficacy of TKP on the biochemical indices in constipated mice, the gastrointestinal regulation-related neurotransmitters, including NO, VIP, ET-1, SP, MTL and ACH, were assayed. As indicated in Figures 2D–I, the levels of inhibitory neurotransmitters (NO, VIP, and ET-1) in the serum were significantly higher than those in the NC group by 76.6%, 59.6%, and 71.5% (all P < 0.005), respectively, whereas the levels of excitatory neurotransmitters (SP, MTL and ACH) were significantly lower in the MC group compared with the NC group by 32.0%, 26.7%, and 40.0% (P < 0.01 or P < 0.005), respectively. Interestingly, the TKP-treated groups dose-dependently restored these parameters to physiological levels. It was worth noting that under the high dose administration of TKP, the levels of NO, VIP, and ET-1 were notably reduced by 39.7%, 32.0%, and 46.6% (all P < 0.005), respectively. Moreover, the levels of SP, MTL and ACH were obviously elevated by 37.0%, 29.3%, and 46.6%, respectively (P < 0.05 or P < 0.005). Next, the biochemical indices in LPS-induced RAW264.7 macrophage cells were tested (Figure 2J). No significant difference in cell viability under different concentrations of TKP treatment was observed (Figure 2K), indicating that TKP did not have toxic effects on RAW264.7 cells. As presented in Figure 2L, the level of NO was significantly increased in the model group when compared with the control group (all P < 0.005). In comparison with the model group, the levels of NO under the concentrations at 0.2, 0.4, and 0.8 mg/mL of TKP treatment were obviously decreased (all P < 0.005).
3.3 Immunohistochemical image analysis of the colon in constipated mice
The immunostaining images analysis of VIPR1 and HTR4-positive cells in the colon tissue of constipated mice were demonstrated in Figures 3A–D. In term of VIPR1 expression, the NC group showed a low proportion of VIPR1-positive cells, and the proportion of VIPR1-positive cells in the MC group was significantly elevated by 6.5% (P < 0.005). Among the TKP-treated groups, the proportion of VIPR1-positive cells tended to decreased with the increase of the dose. Especially in the TKP-H group, the proportion reached about 3.5% (P < 0.005), close to the level of the NC group. Nevertheless, the expression level of HTR4 was opposite to that of VIPR1. After gavage of diphenoxylate, the proportion of HTR4-positive cells was lower in the MC group than that of those in the NC group. The proportion of HTR4-positive cells in the TKP-treated groups tended to increase with dose, displaying a clear dose-dependent condition. The immunohistochemical results illustrated that TKP treatment was able to up-regulate the expression level of HTR4 and down-regulate the expression of VIPR1 in the colon of constipated mice, especially at high doses.
FIGURE 3
3.4 Improvement of intestinal inflammatory factors and mucosal barrier by TKP in constipated mice
Inflammatory response and impaired mucosal barrier in the colon tissue are important features of constipation. As shown in Figure 4A, histological examination revealed the regular mucosal folds and tightly arranged cells in the NC group. However, mice in the MC group had an abnormal colon condition, which was mainly characterized by the mucosa and submucosa exhibiting obvious signs of inflammatory infiltration. In contrast, the BC and TKP-H groups maintained intact villus architecture, exhibiting histological organization comparable to healthy controls. Morphometric analysis revealed significant reductions in the MC group mice of colonic muscular layer thickness (by 38.5%, P < 0.005) and villus length (by 25.7%, P < 0.005), along with a 43.7% increase in crypt depth (P < 0.01) when compared with the NC group (Figures 4B–D). Nevertheless, TKP treatment dose-dependently ameliorated these changes, especially TKP-H showing bisacodyl-equivalent activity (P < 0.01).
FIGURE 4
To further explore colonic inflammation in constipated mice, we measured the levels of the inflammation-related factors including IL-6, IL-1β, and TNF-α. As shown in Figures 4E–G, with regard to the NC group, the levels of TNF-α, IL-1β, and IL-6 were significantly elevated by 39.5%, 29.6%, and 47.9%, respectively (P < 0.01 or P < 0.005). After the TKP-M and TKP-H intervention, the levels of IL-6, IL-1β, and TNF-α were significantly reduced compared with the MC group (P < 0.05 or P < 0.01). ZO-1 and occludin are key tight junction proteins, playing a vital role in maintaining tight junctions between intestinal epithelial cells and safeguarding the integrity of the intestinal barrier. Thus, the expression levels of ZO-1 and occludin proteins in the colon tissue were measured (Figures 4H–J). The results indicated that the expression levels of ZO-1 and occludin were significantly lower in the MC group compared with the NC group (all P < 0.01). Notably, TKP treatment dose-dependently upregulated the expression levels of ZO-1 and occludin. These findings correlated with histological observation from HE-stained colon sections, indicating that TKP treatment enhanced the intestinal barrier function.
3.5 Effect of TKP on short chain fatty acids (SCFAs) in constipated mice
The levels of SCFAs in feces of constipated mice were measured. As summarized in Table 1, the levels of acetic acid, propionic acid, isobutyric acid, butyric acid, isovaleric acid, and valeric acid in feces of the MC group mice were significantly decreased by 37.4%, 49.2%, 61.6%, 64.1%, 78.7%, and 73.2% (all P < 0.01), respectively, compared with NC group. Importantly, with regard to the MC group, the contents of acetic acid, propionic acid, isobutyric acid, butyric acid, isovaleric acid, and valeric acid in the TKP-H group were significantly increased by 58.0%, 83.9%, 115.5%, 145.6%, 242.2% (P < 0.05 or P < 0.01), respectively. These results indicated that the TKP treatment gradually restored the production of SCFAs, and the TKP-H group reached a level comparable to that of the BC group.
TABLE 1
| Groups | Acetic acid | Propionic acid | Isobutyric acid | Butanoic acid | Isovaleric acid | Valeric acid |
| NC | 320.16 ± 27.38 | 73.97 ± 5.44 | 4.04 ± 0.79 | 127.68 ± 22.32 | 2.11 ± 0.14 | 6.56 ± 0.95 |
| MC | 200.36 ± 23.05** | 37.56 ± 11.26** | 1.55 ± 0.36** | 45.90 ± 17.65** | 0.45 ± 0.25** | 1.76 ± 0.37** |
| BC | 305.77 ± 25.07# | 73.09 ± 5.48## | 3.75 ± 0.90# | 117.84 ± 18.40# | 1.62 ± 0.57# | 5.85 ± 0.66# |
| TKP-L | 230.12 ± 17.83 | 52.70 ± 11.14 | 2.31 ± 0.72 | 70.68 ± 16.17 | 1.13 ± 0.26 | 3.37 ± 1.37 |
| TKP-M | 279.25 ± 35.67 | 60.22 ± 7.54# | 2.57 ± 0.49 | 74.60 ± 21.54 | 1.18 ± 0.28 | 3.67 ± 2.10 |
| TKP-H | 316.48 ± 54.55## | 69.06 ± 5.65## | 3.34 ± 0.48# | 112.74 ± 28.56# | 1.54 ± 0.48# | 4.98 ± 0.72# |
Effect of Trichosanthes kirilowii polysaccharide on short-chain fatty acids in the contents of the cecum (ng/mg).
NC, the normal control group; MC, the model control group; BC, the bisacodyl positive control group; TKP-L, 300 mg/kg⋅bw/d TKP group; TKP-M, 600 mg/kg⋅bw/d TKP group; TKP-H, 900 mg/kg⋅bw/d TKP group. Data are expressed as means ± SD (n = 8 mice/group).
**P < 0.01 vs, NC group;
#P < 0.05 vs. MC group,
##P < 0.01 vs. MC group.
3.6 Gut microbiota composition analysis
To explore the influence of TKP on the gut microbiota of constipated mice, 16S rRNA sequencing was conducted in the cecal contents. Alpha diversity analysis was performed to assess species abundance and diversity. As shown in Figures 5A–E, in comparison with the NC group, Sobs, Ace, Chao, Simpson and Shannon indexes decreased in the MC group, indicating that the richness of community distribution was decreased. After the TKP treatment, Sobs, Ace, Chao, Simpson, and Shannon indexes were increased in a dose dependent manner, suggesting that TKP could restore intestinal microbiota diversity, especially the TKP-H group. The coverage index is used to assess the depth and accuracy of sequencing data. The coverage index in all groups was close to 1 (Figure 5F), indicating that this sequencing was able to realistically reflect the microbial composition of the samples. Common and unique operational taxonomic units (OTUs) between different groups were analyzed by Venn diagrams. As shown in Figure 5G, the number of common OTUs in the six groups was 523. Meanwhlie, the NC group had 63 unique OTUs, and the MC group had 13 unique OTUs, while the TKP-L, TKP-M, and TKP-H groups had 15, 37, and 17 unique OTUs, respectively. In addition, PCA analysis indicated a better taxonomic aggregation of microbial communities in all groups. In particular, the three dosing groups can be clearly distinguished from the MC group (Figure 5H).
FIGURE 5
Based on the results of 16S rRNA gene sequencing in mice, the gut microbiota structural differences among the groups were further analyzed at the phylum and genus levels. As illustrated in Figure 6A, at the phylum level, Bacteroidota and Bacillota were the dominant phyla across all groups. Compared with the NC group, the MC group mice exhibited a significantly lower relative abundance of Bacteroidota (P < 0.005). Conversely, the relative abundance of Bacillota in the MC group was significantly higher than that of those in the NC group (P < 0.005). Nevertheless, TKP treatment effectively reversed the microbial imbalance (Figures 6B, C). Specifically, in the TKP-H group, the relative abundance of Bacteroidota was increased by 55.2% (P < 0.005), while that of Bacillota was decreased by 20.5% (P < 0.005), when compared with the MC group.
FIGURE 6
At the genus level, (Figure 6D) the primary genera that exhibited significant alterations were norank_f_Muribaculaceae, norank_f_Prevotellaceae, Lachnospiraceae_NK4A136_group, Bacteroides, Alistipes, and norank_f_Oscillospiraceae (Figures 6E–J). Compared with the NC group, the MC group mice exhibited an elevated relative abundances of norank_f_Muribaculaceae, Alistipes, and norank_f_Oscillospiraceae, while the relative abundances of norank_f_Prevotellaceae and Bacteroides were obviously reduced (P < 0.05, P < 0.01, or P < 0.005). Compared with the MC group, under TKP intervention, the relative abundances of norank_f_Muribaculaceae, Alistipes, and norank_f_Oscillospiraceae were decreased, while the relative abundances of norank_f_Prevotellaceae, Lachnospiraceae_NK4A136_group, and Bacteroides were increased, with significant elevation observed in the TKP-H group. These results demonstrated that TKP possessed the capability to modulate the gut microbiota, restoring its abundance and diversity.
3.7 Correlation between physiological indices and relative abundance of bacterial genera in constipated mice
The Spearman correlation coefficient was calculated to investigate the correlation between physiological indices and the relative abundance of bacterial genera in constipated mice. As depicted in Figure 7, the relative abundances of norank_f_Prevotellaceae and Prevotellaceae_UCG-001 exhibited the significant positive correlations with biochemical markers, including the expression levels of ZO-1 (P < 0.005 or P < 0.05) and occludin (all P < 0.01), the level of SP (P < 0.01 or P < 0.05), and GI transit ratio (all P < 0.01). In contrast, negative correlations were observed with the levels of TNF-α (all P < 0.05), IL-6 (P < 0.005 or P < 0.01), and the expression level of VIPR1 (P < 0.05 or P < 0.005). Moreover, the relative abundances of norank_f_Lachnospiraceae and Lachnospiraceae_NK4A136_group presented statistically positive correlations with the levels of SOD (P < 0.01 or P < 0.05) and ACH (P < 0.005 or P < 0.01). Notably, Bacteroides and norank_f_Prevotellaceae displayed inverse correlations with the level of IL-1β (P < 0.01 or P < 0.05), with norank_f_Oscillospiraceae and Lachnospiraceae_NK4A136_group showing significant positive association (P < 0.01 or P < 0.05).
FIGURE 7
4 Discussion
Functional constipation, a chronic condition that is now widespread, has a profound and lasting negative impact on an individual’s health. Natural polysaccharides, as a class of natural macromolecules with minimal adverse reaction, extensive bioactivity and significant therapeutic effect, have garnered considerable attention in recent years due to their notable advantages in treating functional constipation (; ). Previous studies on constipation primarily focused on cases where constipation had already developed and colonic damage was present (). Therefore, implementing preventive interventions to maintain intestinal integrity prior to gut dysfunction is physiologically imperative. Importantly, our study is the first to investigate the role of polysaccharides from Trichosanthes kirilowii Maxim in the prevention of constipation. We found that TKP, a major constituent of Trichosanthes kirilowii Maxim, can effectively ameliorate constipation symptoms by regulating gastrointestinal neurotransmitters and alleviating intestinal microbial dysbiosis, thereby satisfactorily preventing the occurrence of functional constipation.
Constipation is characterized by the difficulty in defecation and the increased defecation time (). In our study, TKP significantly increased the number and wet weight of black feces, and GI transit ratio in constipated mice, while the time of the first black feces was shortened, thereby alleviating constipation symptoms (Figures 1B–E). The formation of intestinal oxidative stress and the destruction of the antioxidant enzyme system are important causes of constipation (). Our study indicated that TKP-H significantly improved the serum levels of antioxidant enzymes (Figures 2A–C). Intestinal neurotransmitters play a crucial role in regulating intestinal motility. An overproduction of inhibitory neurotransmitters and an underproduction of excitatory neurotransmitters can impair intestinal motility, leading to constipation (; ). Administration of TKP was found to enhance the levels of excitatory neurotransmitters including SP, MTL and ACH, while reducing the levels of inhibitory neurotransmitters such as NO, VIP and ET-1, as measured by serum assays in constipated mice (Figures 2D, E). VIPR1 and HTR4 play an important role in the colon (). The protein encoded by the VIPR1 gene is a receptor for VIP, which is engaged in the modulation of neurotransmission and endocrine function, and the HTR4 receptor has an extensive spread in the gastrointestinal tract, which is participated in the regulation of gastrointestinal peristalsis and secretion (; ). In our study, immunohistochemical analysis revealed that TKP treatment upregulated the expression of HTR4 as well as the downregulated expression of VIPR1 in constipated mice, with these modulatory effects being most pronounced at high doses (Figure 3). These findings demonstrated that TKP exerted the significant anti-constipation effects by coordinately downregulating the inhibitory neurotransmitter/receptor activity while upregulating the excitatory neurotransmission pathways.
It is the pivotal therapeutic strategies for mitigating intestinal inflammation by reducing the release of pro-inflammatory cytokine (; ; ). Notably, the TKP-H group showed profound attenuation of colonic inflammation, evidenced by the decreased concentrations of TNF-α, IL-1β and IL-6 (Figures 4E–G). Studies have demonstrated that the pathogenesis of functional constipation is closely related to the integrity of the intestinal barrier (). Intestinal barrier dysfunction increases the permeability and induces the mucosal damage, while concomitant inflammatory responses exacerbate epithelial injury, further compromising barrier integrity (). TKP treatment enhanced the expression of the intestinal permeability-associated tight junction proteins ZO-1 and occludin in constipated mice (Figures 4H–J).
Short-chain fatty acids are substances produced primarily by anaerobic bacteria in the intestinal tract through the fermentation of undigested carbohydrates, and usually have significant physiological regulatory functions, such as protecting the intestinal mucosal barrier and inhibiting intestinal inflammation (). Our results demonstrated that the constipated state impaired the intestinal homeostasis, leading to the reduced production of SCFAs. Crucially, TKP intervention elevated the concentrations of SCFAs, thereby creating essential biochemical conditions for intestinal integrity.
Accumulating evidence establishes the gut microbiota as a critical regulator in functional constipation pathogenesis (). Gut microbiota dysbiosis is intimately linked to the inflammatory responses and intestinal barrier integrity. Artemisia argyi polysaccharide (AAP) has been demonstrated to alleviate intestinal inflammation and gut microbiota dysbiosis in mice, playing a crucial role in maintaining intestinal barrier integrity (). To investigate the impact of TKP on the gut microbiota in constipated mice, we performed the 16S rRNA gene sequencing on cecal content of mcie. Results revealed that mice in the MC group exhibited significant microbial dysbiosis. Bacteroidota and Bacillota constitute the predominant phyla of the gut microbiota (). Bacteroidota rank among the primary colonizers in the gut, and their utilization of polysaccharides is essential for maintaining functional stability within the intestinal microbial ecosystem (). Bacteroidota can produce more polysaccharide-degrading enzymes than Bacillota, as evidenced by genomic analyzes (). At the phylum level, TKP treatment altered the relative abundances of Bacteroidota and Bacillota (Figures 6B, C). At the genus level, the relative abundances of beneficial bacterial genera, including norank_f_Prevotellaceae, Lachnospiraceae_NK4A136_group and Bacteroides were restored, with particularly significant effects observed in the TKP-H group (Figures 6F–H). Spearman’s correlation analysis was subsequently employed to quantify relationships between physiological parameters and genus-level microbial abundances in constipated mice. Previous study has reported a positive correlation between Bacteroides abundance and SP level, suggesting that increased relative abundance of Bacteroides may contribute to ameliorating constipation symptoms in constipated mice (). Lachnospiraceae_NK4A136_group exhibits potent anti-inflammatory activity and enhances mucosal restitution in the intestinal epithelium (). In this study, Spearman’s correlation analysis identified the significant positive correlations between norank_f_Prevotellaceae and Lachnospiraceae_NK4A136_group and the levels of ZO-1, occludin and SP, while was significantly negative correlations with the levels of TNF-α, IL-6 and VIPR1 (Figure 7). Additionally, Bacteroides exhibited a significant negative correlation with the level of IL-1β. These findings elucidated the mechanism for the anti-constipation effect of TKP, partially involving microbial pathway modulation.
5 Conclusion
In conclusion, TKP effectively facilitated the defecation function, and ameliorated the secretion levels of neurotransmitters, inflammatory response and oxidative stress in constipated mice. Importantly, TKP repaired the intestinal barrier and restored the composition of the gut microbiota. These therapeutic effects alleviated the diphenoxylate-induced functional constipation, establishing TKP as a potent dietary therapy for constipation.
Statements
Data availability statement
The original contributions presented in the study are publicly available. This data can be found here: NCBI BioProject, accession PRJNA1309862.
Ethics statement
The animal study was approved by the Ethics Committee of Shandong Academy of Traditional Chinese Medicine (SDZYY20230621003). The study was conducted in accordance with the local legislation and institutional requirements.
Author contributions
MJ: Investigation, Methodology, Writing – original draft. CW: Investigation, Resources, Writing – review & editing. JC: Investigation, Validation, Writing – review & editing. GW: Methodology, Writing – review & editing. WL: Investigation, Visualization, Writing – review & editing. TL: Investigation, Visualization, Writing – review & editing. XW: Funding acquisition, Project administration, Writing – review & editing.
Funding
The author(s) declare that financial support was received for the research and/or publication of this article. This research was supported by the Key Research and Development Program of Shandong Province (2023TZXD080), and Taishan Scholars Program of Shandong Province (tstp20221138 and tsqnz20231230).
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Generative AI statement
The authors declare that no Generative AI was used in the creation of this manuscript.
Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Supplementary material
The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fmicb.2025.1672600/full#supplementary-material
References
1
ArunratK.WangtueaiS.PalanisamyS.YouS.Rod-inW.SurayotU. (2025). Sulfated fucan polysaccharide from Holothuria scabra attenuates LPS-induced inflammation in RAW264. 7 macrophages via modulation of NF-κB and MAPK signalling pathways.J. Agric. Food Res.22:102122. 10.1016/j.jafr.2025.102122
2
BarberioB.JudgeC.SavarinoE. V.FordA. C. (2021). Global prevalence of functional constipation according to the Rome criteria: A systematic review and meta-analysis.Lancet Gastroenterol. Hepatol.6638–648. 10.1016/s2468-1253(21)00111-4
3
BharuchaA. E.LacyB. E. (2020). Mechanisms, evaluation, and management of chronic constipation.Gastroenterology1581232–1249. 10.1053/j.gastro.2019.12.034
4
CaiW. F.LinS. X.MaP. Y.ShenC. Y. (2023). Semen Pruni oil attenuates loperamide-induced constipation in mice by regulating neurotransmitters, oxidative stress and inflammatory response.J. Funct. Food107:105676. 10.1016/j.jff.2023.105676
5
CamilleriM.FordA. C.MaweG. M.DinningP. G.RaoS. S.CheyW. D.et al (2017). Chronic constipation.Nat. Rev. Dis. Primers.31–19. 10.1038/nrdp.2017.96
6
ChenM.XiaoD.LiuW.SongY.ZouB.LiL.et al (2020). Intake of Ganoderma lucidum polysaccharides reverses the disturbed gut microbiota and metabolism in type 2 diabetic rats.Int. J. Biol. Macromol.155890–902. 10.1016/j.ijbiomac.2019.11.047
7
ChenS.WangJ.FangQ.DongN.FangQ.CuiS. W.et al (2021). A polysaccharide from natural Cordyceps sinensis regulates the intestinal immunity and gut microbiota in mice with cyclophosphamide-induced intestinal injury.Food Funct.126271–6282. 10.1039/d1fo00596k
8
ChenT.ZhangM.LiJ.SurhioM. M.LiB.YeM. (2016). Structural characterization and hypoglycemic activity of Trichosanthes peel polysaccharide.Lwt7055–62. 10.1016/j.lwt.2016.02.024
9
ChengJ.HuJ.GengF.NieS. (2022). Bacteroides utilization for dietary polysaccharides and their beneficial effects on gut health.Food Sci. Hum. Well.111101–1110. 10.1016/j.fshw.2022.04.002
10
DongQ.ChenD.ZhangY.XuY.YanL.JiangJ. (2023). Constipation and cardiovascular disease: A two-sample Mendelian randomization analysis.Front. Cardiovasc. Med.10:1080982. 10.3389/fcvm.2023.1080982
11
GanQ.ChenL.XianJ.AnG.WeiH.MaY. (2024). Digestive characteristics of Gastrodia elata Blume polysaccharide and related impacts on human gut microbiota in vitro.J. Ethnopharmacol.328:118064. 10.1016/j.jep.2024.118064
12
GuanC.ZhangY.WangH.ChenQ.PangX.CuiX.et al (2024). Effects of wheat germ polysaccharides prepared by ultra-high pressure on functional constipation and gut microbiota.Food Biosci.57:103347. 10.1016/j.fbio.2023.103347
13
GuoY.SongL.HuangY.LiX.XiaoY.WangZ.et al (2023). Latilactobacillus sakei Furu2019 and stachyose as probiotics, prebiotics, and synbiotics alleviate constipation in mice.Front. Nutr.9:1039403. 10.3389/fnut.2022.1039403
14
HanC.GengQ.QinJ.LiY.YuH. (2022). Activation of 5-hydroxytryptamine 4 receptor improves colonic barrier function by triggering mucin 2 production in a mouse model of type 1 diabetes.Am. J. Pathol.192876–886. 10.1016/j.ajpath.2022.03.002
15
HeH.WangJ.GongP.XiaoY.LiS.WangJ.et al (2024). Structural identification and immunomodulatory effects of chicken egg white glycopeptides.LWT200:116195. 10.1016/j.lwt.2024.116195
16
HuT. G.WenP.FuH. Z.LinG. Y.LiaoS. T.ZouY. X. (2019). Protective effect of mulberry (Morus atropurpurea) fruit against diphenoxylate-induced constipation in mice through the modulation of gut microbiota.Food Funct.101513–1528. 10.1039/c9fo00132h
17
HuZ.ZhouH.ZhaoJ.SunJ.LiM.SunX. (2020). Microwave-assisted extraction, characterization and immunomodulatory activity on RAW264. 7 cells of polysaccharides from Trichosanthes kirilowii Maxim seeds.Int. J. Biol. Macromol.1642861–2872. 10.1016/j.ijbiomac.2020.08.072
18
JiangH. Y.MaR. A.JiF. L.LiuY.WangB.FuS. Q.et al (2024). Structure characterization of polysaccharides from Cistanche deserticola and their neuroprotective effects against oxidative stress in slow transit constipation mice.Int. J. Biol. Macromol.260:129527. 10.1016/j.ijbiomac.2024.129527
19
JiangH.DongJ.JiangS.LiangQ.ZhangY.LiuZ.et al (2020). Effect of Durio zibethinus rind polysaccharide on functional constipation and intestinal microbiota in rats.Food Res. Int.136:109316. 10.1016/j.foodres.2020.109316
20
JiangY.CaoR. X.LeiX.WangZ. L.HuangX. L.DiJ. R.et al (2024). Structural characterization of polysaccharide from the peel of Trichosanthes kirilowii Maxim and its anti-hyperlipidemia activity by regulating gut microbiota and inhibiting cholesterol absorption.Bioorg. Chem.149:107487. 10.1016/j.bioorg.2024.107487
21
KielkopfC. L.BauerW.UrbatschI. L. (2020). Bradford assay for determining protein concentration.CSH Protoc.2020:102269. 10.1101/pdb.prot102269
22
KimJ. E.ChoiY. J.LeeS. J.GongJ. E.LeeY. J.SungJ. E.et al (2021). Antioxidant activity and laxative effects of tannin-enriched extract of Ecklonia cava in loperamide-induced constipation of SD rats.PLoS One16:e0246363. 10.1371/journal.pone.0246363
23
LapébieP.LombardV.DrulaE.TerraponN.HenrissatB. (2019). Bacteroidetes use thousands of enzyme combinations to break down glycans.Nat. Commun.10:2043. 10.1038/s41467-019-10068-5
24
LiJ.ZhengH.LiuJ.DingJ.GuoQ.ZhangN. (2024). Effects of functional red pine seed direct-drinking oil on constipation and intestinal barrier function in mice.Antioxidants14:14. 10.3390/antiox14010014
25
LiT.ChenJ.XuY.JiW.YangS.WangX. (2025). Hawthorn pectin alleviates DSS-induced colitis in mice by ameliorating intestinal barrier function and modulating gut microbiota.J. Agric. Food Chem.735872–5885. 10.1021/acs.jafc.4c07965
26
LiT.YanQ.WenY.LiuJ.SunJ.JiangZ. (2021). Synbiotic yogurt containing konjac mannan oligosaccharides and Bifidobacterium animalis ssp. lactis BB12 alleviates constipation in mice by modulating the stem cell factor (SCF)/c-Kit pathway and gut microbiota.J. Dairy Sci.1045239–5255. 10.3168/jds.2020-19449
27
LiuC. J.TangX. D.YuJ.ZhangH. Y.LiX. R. (2017). Gut microbiota alterations from different Lactobacillus probiotic-fermented yoghurt treatments in slow-transit constipation.J. Funct. Foods38110–118. 10.1016/j.jff.2017.08.037
28
LiuJ.WangS.YiR.LongX.LuoG.ZhaoX.et al (2023). LimosiLactobacillus pentosus isolated from mustard relieves drug-induced constipation in mice fed a high-fat diet by modulating enteric neurotransmitter function.Probiotics Antimicro.151371–1381. 10.1007/s12602-022-09991-9
29
LiuX.ChenS.YanQ.LiY.JiangZ. (2019). Effect of Konjac mannan oligosaccharides on diphenoxylate-induced constipation in mice.J. Funct. Foods57399–407. 10.1016/j.jff.2019.04.036
30
LuJ.HeR.SunP.ZhangF.LinhardtR. J.ZhangA. (2020). Molecular mechanisms of bioactive polysaccharides from Ganoderma lucidum (Lingzhi), a review.Int. J. Biol. Macromol.150765–774. 10.1016/j.ijbiomac.2020.02.035
31
LuoD.QuC.LinG.ZhangZ.XieJ.ChenH.et al (2017). Character and laxative activity of polysaccharides isolated from Dendrobium officinale.J. Funct. Foods34106–117. 10.1016/j.jff.2017.04.024
32
NingE. J.SunC. W.WangX. F.ChenL.LiF. F.ZhangL. X.et al (2024). Artemisia argyi polysaccharide alleviates intestinal inflammation and intestinal flora dysbiosis in lipopolysaccharide-treated mice.Food Med. Homol.1:9420008. 10.26599/FMH.2024.9420008
33
SahakianL.FilipponeR. T.StavelyR.RobinsonA. M.YanX. S.AbaloR.et al (2021). Inhibition of APE1/Ref-1 redox signaling alleviates intestinal dysfunction and damage to myenteric neurons in a mouse model of spontaneous chronic colitis.Inflamm. Bowel Dis.27388–406. 10.1093/ibd/izaa161
34
ShiX. Z.ChoudhuryB. K.PasrichaP. J.SarnaS. K. (2007). A novel role of VIP in colonic motility function: Induction of excitation-transcription coupling in smooth muscle cells.Gastroenterology1321388–1400. 10.1053/j.gastro.2007.02.016
35
SousaT. B.MotaG. D. S.AraujoE. D. S.CarreraJ. C.SilvaE. P.SouzaS. G.et al (2022). Chemical and structural characterization of Myracrodruon urundeuva barks aiming at their potential use and elaboration of a sustainable management plan.Biomass Convers. Biorefin.121583–1593. 10.1007/s13399-020-01093-2
36
StallerK.OlénO.SöderlingJ.RoelstraeteB.TörnblomH.SongM.et al (2022). Chronic constipation as a risk factor for colorectal cancer: Results from a nationwide, case-control study.Clin. Gastroenterol. Hepatol.201867–1876. 10.1016/j.cgh.2021.10.024
37
SuH.ChenJ.MiaoS.DengK.LiuJ.ZengS.et al (2019). Lotus seed oligosaccharides at various dosages with prebiotic activity regulate gut microbiota and relieve constipation in mice.Food Chem. Toxicol.134:110838. 10.1016/j.fct.2019.110838
38
TsaiY. C.TaiW. C.LiangC. M.WuC. K.TsaiM. C.HuW. H.et al (2025). Alternations of the gut microbiota and the Firmicutes/Bacteroidetes ratio after biologic treatment in inflammatory bowel disease.J. Microbiol. Immunol.5862–69. 10.1016/j.jmii.2024.09.006
39
VriesmanM. H.KoppenI. J. N.CamilleriM.LorenzoC.BenningaM. A. (2020). Management of functional constipation in children and adults.Nat. Rev. Gastroenterol. Hepatol.1721–39. 10.1038/s41575-019-0222-y
40
WangZ.WuG.NiuT.GuoY.WangC.WangX.et al (2024). Polysaccharide isolated from Dioscorea septemloba improves hyperuricemia and alleviates renal fibrosis through gut-kidney axis in mice.Int. J. Biol. Macromol.282:137112. 10.1016/j.ijbiomac.2024.137112
41
WuT.SongF.HuangJ.CuiS.WangL.YangQ.et al (2025). Gut microbiota: The pivotal conduit in the onset of constipation and its alleviation by tea flower polysaccharides (TFP) in a mouse model.Int. J. Biol. Macromol.304:140808. 10.1016/j.ijbiomac.2025.140808
42
XuM.WangW.SuS.LiW.HuX.ZhangJ. (2023). Arecoline alleviated loperamide induced constipation by regulating gut microbes and the expression of colonic genome.Ecotoxicol. Environ. Saf.264:115423. 10.1016/j.ecoenv.2023.115423
43
YangH.WuC.ChenL.ChangX.LuoG.WuK.et al (2023). A. macrocephala polysaccharide induces alterations to gut microbiome and serum metabolome in constipated mice.Microb. Pathog.178:106084. 10.1016/j.micpath.2023.106084
44
YangL.WangY.ZhangY.LiW.JiangS.QianD.et al (2022). Gut microbiota: A new avenue to reveal pathological mechanisms of constipation.Appl. Microbiol. Biotechnol.1066899–6913. 10.1007/s00253-022-12197-2
45
YangS. Y.GuoL. F.LiuY.ZouJ. B.ZhuH. Y.LuY.et al (2023). Trichosanates A-G and cucurbitacins W-Y, anticomplement monoterpenoids and cucurbitane-type triterpenoids from the pericarps of Trichosanthes kirilowii.Bioorg. Chem.139:106710. 10.1016/j.bioorg.2023.106710
46
YeD.ZhaoQ.DingD.MaB. L. (2023). Preclinical pharmacokinetics-related pharmacological effects of orally administered polysaccharides from traditional Chinese medicines: A review.Int. J. Biol. Macromol.252:126484. 10.1016/j.ijbiomac
47
YuX.TangL.WuH.ZhangX.LuoH.GuoR.et al (2018). Trichosanthis Fructus: Botany, traditional uses, phytochemistry and pharmacology.J. Ethnopharmacol.224177–194. 10.1016/j.jep.2018.05.034
48
YuY.ShenM.SongQ.XieJ. (2018). Biological activities and pharmaceutical applications of polysaccharide from natural resources: A review.Carbohydr. Polym.18391–101. 10.1016/j.carbpol.2017.12.009
49
ZhangJ.GaoH.ZhuL.YuanX.YangX.XuM.et al (2022a). The protective effect of Trichosanthes kirilowii peel polysaccharide on the oxidative damaged HepG2 and HUASMC cells.Genet. Res.2022:1792977. 10.1155/2022/1792977
50
ZhangJ.GaoN.JiangH.LiH.CuiX.TangS.et al (2022b). Comparative study on alleviating effect of kiwi berry (Actinidia arguta) polysaccharide and polyphenol extracts on constipated mice.Food Res. Int.162:112037. 10.1016/j.foodres.2022.112037
51
ZhangJ.LiB.GaoN.LiH.CuiX.JiangH.et al (2024). Preventive effect of kiwi berry (Actinidia arguta) on loperamide-induced constipation.Food Sci. Hum. Well.131410–1421. 10.1016/j.foodres.2022.112037
52
ZhangX.YangH.ZhengJ.JiangN.SunG.BaoX.et al (2021). Chitosan oligosaccharides attenuate loperamide-induced constipation through regulation of gut microbiota in mice.Carbohydr. Polym.253:117218. 10.1016/j.carbpol.2020.117218
53
ZhongY. B.KangZ. P.WangM. X.LongJ.WangH. Y.HuangJ. Q.et al (2021). Curcumin ameliorated dextran sulfate sodium-induced colitis via regulating the homeostasis of DCs and Treg and improving the composition of the gut microbiota.J. Funct. Foods86:104716. 10.1016/j.jff.2024.106146
Summary
Keywords
functional constipation, polysaccharide, Trichosanthes kirilowii Maxim, gut microbiota, neurotransmitters
Citation
Jiang M, Wang C, Chen J, Wu G, Liu W, Li T and Wang X (2025) Polysaccharide from Trichosanthes kirilowii Maxim ameliorates diphenoxylate-induced functional constipation in mice. Front. Microbiol. 16:1672600. doi: 10.3389/fmicb.2025.1672600
Received
24 July 2025
Accepted
19 August 2025
Published
23 September 2025
Volume
16 - 2025
Edited by
Shanshan Hu, Anhui Agricultural University, China
Reviewed by
Ali Movahedi, Nanjing Forestry University, China
Xiaohong Sun, Zhejiang Ocean University, China
Updates
Copyright
© 2025 Jiang, Wang, Chen, Wu, Liu, Li and Wang.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Tao Li, litaosd@qlu.edu.cnXiao Wang, wangx@sdas.org
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.